A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
Clinical trial NCT00712855 · COMPLETED
Trial details
- NCT number
- NCT00712855
- Sponsor
- Human Genome Sciences Inc., a GSK Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2011-08-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.